Figure 2.

Cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from 27 February 2020 until 30 April 2021 among participants in the AGE_hIV coronavirus disease 2019 substudy, Amsterdam. Follow-up started on 27 February 2020 and continued until the date of the last SARS-CoV-2 nucleocapsid antibody measurement, loss to follow-up, or death, whichever occurred first. Numbers of participants at risk and numbers with incident infection at the end of each time interval are shown. P values are based on log-rank test. Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus.